New Safely Absorbable Orthopedic Implant Developed
24 Nov 2011 • by Natalie Aster
Researchers from the University of Florida, Gainesville, have been successful in developing a nontoxic magnesium alloy for biomedical applications with lesser quantities of calcium and strontium. Pure magnesium’s softness can lead to premature degradation, while adding high levels of calcium or strontium can result in an excessively rigid implant. Designing a final product that is accurate in mimicking real bone tissue’s mechanical properties has been the result of meticulous design. These devices can be safely absorbed by the body after they are no longer required. Comprising a magnesium alloy with appropriate quantities of calcium and strontium, such implants can mimic natural bone’s mechanical properties, in addition to promoting osteoblast cell function to expedite recovery times. The University of Florida is on the lookout for companies keen to commercialize nontoxic biomedical implants for stabilizing fractures or for temporarily assisting in the damaged bone’s healing process.
Non-response of traditional treatments to orthopedic implants leaves no option but to go in for surgical implants for reducing pain and increasing mobility. Developed countries are faced with the additional onus of an aging population and rampant obesity that form the primary drivers for such devices. These newly developed nontoxic implants, in addition to being completely dissolvable once the body has repaired itself, also accelerate the healing time and lessen the risk to healthy bone tissue from stress shielding, which is not provided by overly rigid implants. Benefits include:
- In the body for only as long as required, minimizing allergy and sensitization issues;
- Does not need surgery for removal, thereby enhancing patient comfort and reducing costs;
- Using calcium and strontium enables in faster bone formation, offering speedier recovery;
- Replicating natural bone offers greater implant stability and minimal risk to healthy bone tissue from stress shielding.
Orthopedic Implants - A Global Market Overview
Published: November 2011
Price: US$ 4,050.00
Report Sample Abstract
Latest Trends in Total Knee Replacement Surgery: Advances and Issues
Over the last 20 years, total knee replacement (TKR) surgery has become increasingly popular, surpassing hip replacement surgery as the most common joint replacement procedure worldwide.
Advancements over the years have reinforced surgeons’ efficacy in this procedure to the extent that they are now offering this procedure to patients more readily. Outcome, too, has been highly impressive, with majority of patients expressing satisfaction.
The market shares of key global players that are engaged in Orthopedic Implants market is analyzed for the year 2010. The analysis is carried out for major product segments – Orthopedic Joint Implants, Orthopedic Trauma Implants and Other Orthopedic Implants that includes spinal and biologics.
Orthopedic Joint Implants
Accounting for slightly over one-fourth of the global market share, Zimmer is estimated the largest manufacturer of joint implants in 2010. JNJ Depuy and Stryker closely follow Zimmer with xx% and xx% market shares respectively. The global market for orthopedic joint implants is estimated at US$xx.x billion in 2010.
Demand for Joint Implants, estimated at US$xx.x billion in 2011 and forecast at US$xx.x billion in 2012, is further projected to record a CAGR of x.x% over 2007-2017 in reaching just over US$xx billion by 2017. The US accounts for an estimated share of xx.x% in 2011, making it the largest market, whereas fastest growth for Joint Implants is expected to be witnessed by Asia-Pacific, with a 2007-2017 compounded rate of x.x%. Market for these implants in the region is projected to reach US$x billion by 2017, compared to an estimated US$x.x billion in 2011.
More information can be found in the report “Orthopedic Implants - A Global Market Overview” by Industry Experts.
To order the report or ask for sample pages contact [email protected]